In vivo detection of tumor apoptosis using a novel PET/NIRF imaging probe: 18F-PSVue643
10.3760/cma.j.issn.2095-2848.2016.06.011
- VernacularTitle:18F-PSVue643 PET/近红外肿瘤凋亡显像
- Author:
Xinlu WANG
;
Guoquan LI
;
Jinhe ZHANG
;
Xiangdong LI
;
Zheng ZHOU
;
Xi OUYANG
;
Jilin YIN
- Keywords:
Molecular probes;
Phosphatidylserines;
Glioblastoma;
Apoptosis;
Tomography,emission-computed;
Optical imaging;
Mice,nude
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2016;36(6):529-532
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the ability of a synthetic PET/NIRF probe,named 18F-PSVue643,on the apoptosis detection in animal models with the anti-cancer drugs therapy,and compare the advantages and disadvantages between PET and NIRF.Methods Cell apoptosis was detected by MTT and flow cytometry in vitro.Established U87MG glioblastoma xenograft tumors in nude mice were treated with retinol and paclitaxel for nine days (for PET imaging) or eleven days (for NIRF imaging) continuously.The uptake values were recorded by ROI and expressed as ％ID/g.Results The apoptosis ratios in 10 and 100 nmol/L paclitaxel-treated groups were 7.4％ and 7.5％,respectively,and the apoptosis ratio of the control group was 4.3％.The apoptosis could be well detected by both NIRF and PET imaging during the whole process of treatment.However,the amount of probe for PET imaging was only a half of that for optical imaging to get the same apoptosis visualization.Conclusion 18F-PSVue643 is suitable for NIRF and PET imaging in detection of apoptosis,and it may be a promising agent for further clinical studies.
